MedPath

Behavioral Counseling Intervention Trial to Reduce Alcohol-related Sexual Risk Behavior Among HIV-negative Men in Namibia

Not Applicable
Completed
Conditions
Alcohol Consumption
Sexual Behavior
Alcohol Abuse
HIV
Interventions
Behavioral: Placebo Intervention
Behavioral: Alcohol-HIV Risk Reduction Counseling
Registration Number
NCT02359487
Lead Sponsor
Centers for Disease Control and Prevention
Brief Summary

The overall purpose of this study is to evaluate an intervention that aims to reduce alcohol-related HIV sexual risk behaviors among HIV-negative men in Namibia. The objectives of the study are to determine the effectiveness of an individual counseling intervention in reducing alcohol-related HIV sexual risk behaviors among men, and in reducing harmful and hazardous alcohol use among men.

Detailed Description

This study involves a randomized controlled trial of 550 HIV-negative adult men recruited from a single Voluntary Counseling and Testing (VCT) center for HIV in Windhoek, Namibia who report harmful or hazardous alcohol consumption and more than one sex partner in the previous three months.

After receiving standard counseling at the VCT center, all men who test HIV-negative will be invited to be screened for eligibility for the study, and if eligible, to consent to enroll. Personnel hired for the study will then administer a baseline survey via Personal Digital Assistant to all enrolled men. Enrolled participants will then be randomized to either an intervention arm, and receive an additional one-hour counseling session and take-home materials plus general alcohol information materials or to a control arm, and receive general alcohol information materials alone. All men enrolled in the study will receive the general alcohol information materials, consisting of a booklet with alcohol health information and a brochure detailing alcohol abuse support services in the local community. Men in the intervention arm will also receive two cellphone text messages one month and four months following enrollment to boost the risk reduction counseling. Follow-up surveys of all participants will be conducted three months and six months after enrollment

Outcomes measured include self-reported data at baseline, three months and six months post-enrollment regarding: 1) Number, proportion of sex acts preceded by alcohol use; 2) Number, proportion of sex acts protected by condoms; 3) Number of sex partners; and 4) Quantity and frequency of alcohol use; 5) Condom use demonstration scores.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
550
Inclusion Criteria
  • Self reported HIV negative status after testing at the Council of Churches Namibia (CCN) NewStart VCT center
  • More than 1 sexual partner in the past 6 months
  • AUDIT screen score 8 to 19
  • Able to provide informed consent
  • Access to a cell phone to retrieve private text messages and calls
  • Plans to stay in the local area for 6 months
  • Able to verbally communicate in English, Oshiwambo, or Afrikaans
Exclusion Criteria
  • Self reported HIV positive status after testing at the CCN NewStart VCT center
  • Less than 1 sexual partner in the past 6 months
  • AUDIT screen score less than 8 or greater than 20
  • Unable to provide informed consent to participate to enroll in the study
  • Unable to retrieve private cell phone text messages and calls
  • Unable to verbally communicate in English, Oshiwambo, or Afrikaans

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlPlacebo InterventionParticipants assigned to the control arm will be given a general alcohol information booklet and an alcohol abuse support services brochure. The alcohol information booklet contains information about responsible drinking, signs and symptoms of alcohol abuse, advice and guidance to reduce alcohol intake, and resources for assistance. The alcohol support services brochure contains times, dates, and locations of peer support and counseling services in the Windhoek region.
InterventionAlcohol-HIV Risk Reduction CounselingThe intervention consists of a 1-hour individual counseling session relating to alcohol consumption and HIV sexual risk behaviors. Intervention counselors will assess alcohol-related sexual risk behaviors through the use of job aids that include a flip chart, guided scripts, activities, role plays, and a take home booklet. Counselors use motivational interviewing and interactive activities to discuss alcohol and HIV myths and facts, participants personal risk behaviors, and a decision-making activity that assists participants in weighing the pros and cons of engaging in risky behavior. Counselors also facilitate role plays to improve communication skills in risky situations, as well as a condom demonstration and skills session, and goal setting. In addition, men in the intervention arm will also receive two cell phone text messages 1-month and 4-months following enrollment to reiterate risk reduction messages.
Primary Outcome Measures
NameTimeMethod
Change in frequency of sex after drinking (measured by count data and proportions)3 months, 6 months after intervention

Sex acts preceded by alcohol use, for up to 4 recent sex partners, measured by count data and proportions

Secondary Outcome Measures
NameTimeMethod
Change in condom skills (measured by a condom use demonstration score, modified 9-item male condom use score (MCUS)3 months, 6 months after intervention

Changes in condom skills, as measured by a condom use demonstration score

Change in frequency of condom use (measured by count data and proportions)3 months, 6 months after intervention

Sex acts protected by condoms, for up to 4 recent sex partners, measured by count data and proportions

Change in number of sex partners3 months, 6 months after intervention

Number of sex partners in preceding 6 months

Change in frequency of alcohol use (measured by AUDIT and CAGE screens)3 months, 6 months after intervention

Quantity and frequency of alcohol use, measured by AUDIT and CAGE screens

© Copyright 2025. All Rights Reserved by MedPath